Evidence map›Paper›PMID 28979182›Full record

ArticleAdvanced functional materials2017

Glycine

Angelo Corti, Anna Maria Gasparri, Michela Ghitti, Angelina Sacchi, Francesco Sudati, Martina Fiocchi, Valentina Buttiglione, Laura Perani, Alessandro Gori, Silvia Valtorta and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Advanced functional materials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Next-generation agents for fluorescence-guided glioblastoma surgery.Bioengineering & translational medicine · 2024
    Article
  3. Review
  4. Article
  5. Nanogold Functionalized With Lipoamide-Frontiers in chemistry · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Angelo CortiIRCCS San Raffaele Scientific Institute and Vita Salute San Raffaele University, Milan, 20132, Italy.
Anna Maria GasparriIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Michela GhittiIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Angelina SacchiIRCCS San Raffaele Scientific Institute and Vita Salute San Raffaele University, Milan, 20132, Italy.
Francesco SudatiIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Martina FiocchiIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Valentina ButtiglioneIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Laura PeraniIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Alessandro GoriIstituto di Chimica del Riconoscimento Molecolare, C.N.R., Via Mario Bianco 9, 20131, Milan, Italy.
Silvia ValtortaIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Rosa Maria MorescoIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Fabio PastorinoIstituto G. Gaslini, Via G. Gaslini 5, 16148, Genoa, Italy.
Mirco PonzoniIstituto G. Gaslini, Via G. Gaslini 5, 16148, Genoa, Italy.
Giovanna MuscoIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Flavio CurnisIRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
Vita-Salute San Raffaele University · ITIstituto Giannina Gaslini · ITInstitute of Chemistry of Molecular Recognition · IT

Funding

Worldwide Cancer Research 14-0066
6 · The paper itself

Abstract

NGR (asparagine-glycine-arginine) is a tumor vasculature-homing peptide motif widely used for the functionalization of drugs, nanomaterials and imaging compounds for cancer treatment and diagnosis. Unfortunately, this motif has a strong propensity to undergo rapid deamidation. This reaction, which converts NGR into

Indexed as

deamidationenzymemolecular dockingN-methylglycinepeptides

Identifiers

PMID28979182
PMCPMC5624507
OpenAlexW2741663140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.